Video

Educated Patient® Breast Cancer Summit: March 7, 2021

Author(s):

CURE staff

View the full CURE Educated Patient Breast Cancer Summit on demand.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of doctor.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Image of smiling doctor.
Image of Doctor.
Related Content
Image of bottle
June 6th 2025

Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation

Roman Fabbricatore
Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Columvi combo enhances survival outcomes vs Rituxan combo in R/R DLBCL: © stock.adobe.com.
June 5th 2025

Columvi Combo Enhances Survival Outcomes in R/R Lymphoma Subgroup

Roman Fabbricatore
Columvi plus chemo had enhanced survival outcomes vs Rituxan plus chemo in patients with relapsed/refractory diffuse large B-cell lymphoma.
cancer horizons image for podcast
December 14th 2023

Conference Highlights from the 2023 ASH Annual Meeting

Brielle Benyon Alex Biese
CURE® recently covered the 2023 American Society of Hematology Annual Meeting. In case you missed it, here is some news that came out of the conference that patients should know about.
Nubeqa/ADT treatment led to positive impacts on HRQoL vs placebo in mHSPC: © stock.adobe.com.
June 4th 2025

Nubeqa Combo Positively Impacts HRQoL vs Placebo in Prostate Cancer Subgroup

Sabrina Serani
Nubeqa and ADT treatment led to positive impacts on health-related quality of life vs placebo in metastatic hormone-sensitive prostate cancer.
Image of lung.
June 3rd 2025

Imdelltra Shows Survival Benefit in Small Cell Lung Cancer

Chris Ryan
Imdelltra improved survival and quality of life versus chemotherapy as second-line treatment for small cell lung cancer, reinforcing it as a new SOC.